MAPK3 and ovarian carcinoma: In addition, a number of key pathways have been implicated in in vitro and in vivo studies of ovarian cancer ascites, including focal adhesion kinase (FAK), AKT, extracellular signal-regulated kinase 1/2 (ERK1/2) and IL-6 production.64–66